When.com Web Search

  1. Ads

    related to: generic drugs for psoriatic arthritis medications approved by fda pills

Search results

  1. Results From The WOW.Com Content Network
  2. Apremilast - Wikipedia

    en.wikipedia.org/wiki/Apremilast

    Apremilast was approved by the US Food and Drug Administration (FDA) in 2014, for treatment of adults with active psoriatic arthritis and moderate to severe plaque psoriasis, and approved in 2019, for oral ulcers associated with Behçet's disease. [21] [22] [23] Apremilast is taken by mouth. [24]

  3. Etanercept - Wikipedia

    en.wikipedia.org/wiki/Etanercept

    It has US Food and Drug Administration (FDA) approval to treat rheumatoid arthritis, juvenile idiopathic arthritis and psoriatic arthritis, plaque psoriasis and ankylosing spondylitis. Tumor necrosis factor alpha (TNFα) is the "master regulator" of the inflammatory (immune) response in many organ systems. Autoimmune diseases are caused by an ...

  4. Ustekinumab - Wikipedia

    en.wikipedia.org/wiki/Ustekinumab

    In September 2013, the US Food and Drug Administration (FDA) approved the use of ustekinumab for the treatment of psoriatic arthritis. [44] In December 2008, Health Canada approved the use of ustekinumab for the treatment of chronic moderate to severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy. [45] [46]

  5. Johnson & Johnson's Stelara Approved for Psoriatic Arthritis

    www.aol.com/news/2013-09-24-news-johnson...

    The Food and Drug Administration (FDA) has approved Johnson & Johnson's psoriatic arthritis treatment Stelara for patients 18 years or older, the company announced Monday. The approved treatment ...

  6. Upadacitinib - Wikipedia

    en.wikipedia.org/wiki/Upadacitinib

    Upadacitinib, sold under the brand name Rinvoq, is a medication used for the treatment of rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn's disease, ankylosing spondylitis, and axial spondyloarthritis.

  7. Bimekizumab - Wikipedia

    en.wikipedia.org/wiki/Bimekizumab

    Bimekizumab, sold under the brand name Bimzelx (/ b ɪ m ˈ z ɛ l ɪ k s / bim-ZEL-iks), is a humanized anti-IL17A, anti-IL-17F, and anti-IL17AF monoclonal antibody [6] [7] that is used to treat plaque psoriasis, psoriatic arthritis, axial spondyloarthritis, ankylosing spondylitis, and hidradenitis suppurativa.

  1. Ads

    related to: generic drugs for psoriatic arthritis medications approved by fda pills